The Lung as a Target Organ of Graft-Versus-Host Disease

Seminars in Hematology - Tập 43 - Trang 42-52 - 2006
Gregory Yanik1, Kenneth R. Cooke1
1Department of Pediatrics, Division of Hematology/Oncology, Blood and Marrow Transplantation Program, University of Michigan Cancer Center, Ann Arbor, MI

Tài liệu tham khảo

Clark, 1993, NHLBI Workshop Summary, Am Rev Respir Dis, 147, 1601, 10.1164/ajrccm/147.6_Pt_1.1601

Crawford, 1993, Clinical course of idiopathic pneumonia after bone marrow transplantation, Am Rev Respir Dis, 147, 1393, 10.1164/ajrccm/147.6_Pt_1.1393

Weiner, 1986, Interstitial pneumonitis after bone marrow transplantation, Ann Intern Med, 104, 168, 10.7326/0003-4819-104-2-168

Crawford, 1993, Acute graft versus host disease and the risks for idiopathic pneumonia after marrow transplantation for severe aplastic anemia, Bone Marrow Transplant, 12, 225

Kantrow, 1997, Idiopathic pneumonia syndrome, Transplantation, 63, 1079, 10.1097/00007890-199704270-00006

Afessa, 2001, Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation, Bone Marrow Transplant, 28, 425, 10.1038/sj.bmt.1703142

Schultz, 1994, Obstructive lung disease in children after allogeneic bone marrow transplantation, Blood, 84, 3212, 10.1182/blood.V84.9.3212.3212

Crawford, 1995, Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality, Am J Respir Crit Care Med, 152, 690, 10.1164/ajrccm.152.2.7633727

Sullivan, 1992, Late complications of allogeneic and autologous bone marrow transplantation, Bone Marrow Transplant, 10, 127

Sanchez, 1997, Long term follow up of immunosuppressive treatment for obstructive airway disease after allogeneic bone marrow transplantation, Bone Marrow Transplant, 20, 403, 10.1038/sj.bmt.1700894

Badier, 1993, Pulmonary function changes 100 days and one year after bone marrow transplantation, Bone Marrow Transplant, 12, 457

Wingard, 1988, Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution, Medicine, 67, 175, 10.1097/00005792-198805000-00004

Yousem, 1995, The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients, Hum Pathol, 26, 668, 10.1016/0046-8177(95)90174-4

Clark, 1999, Idiopathic pneumonia after bone marrow transplantation, Crit Care Med, 27, 1800, 10.1097/00003246-199909000-00016

Yanik, 2002, Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 8, 395, 10.1053/bbmt.2002.v8.pm12171486

Robbins, 1989, Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients, Am J Med, 87, 511, 10.1016/S0002-9343(89)80606-0

Lewis, 2000, Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation, Bone Marrow Transplant, 26, 539, 10.1038/sj.bmt.1702546

Capizzi, 2001, Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation, Bone Marrow Transplant, 27, 1299, 10.1038/sj.bmt.1703075

Wilczynski, 1998, Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer, Am J Respir Crit Care Med, 157, 565, 10.1164/ajrccm.157.2.9705072

Bhalla, 2000, Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support, Am J Respir Crit Care Med, 161, 17, 10.1164/ajrccm.161.1.9903059

Cahill, 1996, Marrow engraftment and clincial manifestations of capillary leak syndrome, Bone Marrow Transplant, 18, 177

Weiner, 1989, Risk factors for interstitial pneumonitis following bone marrow transplantation for severe aplastic anemia, Br J Haematol, 71, 535, 10.1111/j.1365-2141.1989.tb06314.x

Della Volpe, 2002, Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation, Int J Radiat Oncol Biol Phys, 52, 483, 10.1016/S0360-3016(01)02589-5

Fukuda, 2003, Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation, Blood, 102, 2777, 10.1182/blood-2003-05-1597

Down, 1992, The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation, Transplantation, 54, 802, 10.1097/00007890-199211000-00007

Shankar, 2001, Idiopathic pneumonia syndrome after bone marrow transplantation, Int J Exp Pathol, 82, 101, 10.1111/j.1365-2613.2001.iep182.x

Piguet, 1990, Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis, Nature, 344, 245, 10.1038/344245a0

Schmidt, 1984, Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin-1. A potential role for interleukin-1 in the pathogenesis of silicosis, J Clin Invest, 73, 1462, 10.1172/JCI111350

Suter, 1992, High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis, Am Rev Respir Dis, 145, 1016, 10.1164/ajrccm/145.5.1016

Bortin, 1989, Temporal relationships between the major complications of bone marrow transplantation for leukemia, Bone Marrow Transplant, 4, 339

Beschorner, 1978, Lymphocytic bronchitis associated with graft versus host disease in recipients of bone marrow transplants, N Engl J Med, 299, 1030, 10.1056/NEJM197811092991902

Piguet, 1989, Pneumopathies of the graft-versus-host reaction. Alveolitis associated with an increased level of tumor necrosis factor MRNA and chronic interstitial pneumonitis, Lab Invest, 61, 37

Clark, 1998, Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages, J Immunol, 161, 1913, 10.4049/jimmunol.161.4.1913

Cooke, 1996, An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I. The roles of minor H antigens and endotoxin, Blood, 88, 3230, 10.1182/blood.V88.8.3230.bloodjournal8883230

Cooke, 1998, Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation, Blood, 92, 2571, 10.1182/blood.V92.7.2571

Hackman, 1981, Large airway inflammation as a possible manifestation of a pulmonary graft-versus-host reaction in bone marrow allograft recipients, Lab Invest, 44, 26A

Connor, 1982, Pulmonary pathology in bone marrow transplant recipients, Lab Invest, 46, 3

Panoskaltsis-Mortari, 1997, The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogenic recipients are due to donor T cell infusion and potentiated by cyclophoshamide, J Clin Invest, 100, 1015, 10.1172/JCI119612

Curtis, 1995, Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation, Bone Marrow Transplant, 16, 169

Clark, 1987, Risk factors for air-flow obstruction in recipients of bone marrow transplants, Ann Intern Med, 107, 648, 10.7326/0003-4819-107-5-648

Hildebrandt, 2004, Blockade of CXCR3 receptor:ligand interactions reduces leukocyte recruitment to the lung and the severity of experimental idiopathic pneumonia syndrome, J Immunol, 173, 2050, 10.4049/jimmunol.173.3.2050

Cooke, 2000, A role for Fas-Fas ligand but not perforin mediated cytolysis in the development of experimental idiopathic pneumonia syndrome, Blood, 96, 768a

Hildebrandt, 2004, Donor-derived TNF-alpha regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation, Blood, 104, 586, 10.1182/blood-2003-12-4259

Dupuis, 1997, Dendritic-cell regulation of lung immunity, Am J Respir Cell Mol Biol, 17, 284, 10.1165/ajrcmb.17.3.f136

Christensen, 1995, Regulation of rat pulmonary dendritic cell immunostimulatory activity by alveolar epithelial cell-derived granulocyte macrophage colony-stimulating factor, Am J Respir Cell Mol Biol, 13, 426, 10.1165/ajrcmb.13.4.7546772

van Haarst, 1994, Distribution and immunophenotype of mononuclear and dendritic cells in the human lung, Am J Respir Cell Mol Biol, 10, 487, 10.1165/ajrcmb.10.5.8179911

Yousem, 1990, Potential role of dendritic cells in bronchiolitis obliterans in heart-lung transplantation, Ann Thorac Surg, 49, 424, 10.1016/0003-4975(90)90248-5

Holt, 1994, Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways, J Immunol, 153, 256, 10.4049/jimmunol.153.1.256

Piguet, 1987, Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-versus-host disease, J Exp Med, 166, 1280, 10.1084/jem.166.5.1280

Cooke, 2000, Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation, Transplantation, 70, 272, 10.1097/00007890-200007270-00006

Cooke, 2000, Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome, J Immunol, 165, 6612, 10.4049/jimmunol.165.11.6612

Cooke, 1998, Tumor necrosis factor-a production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft versus host disease, J Clin Invest, 102, 1882, 10.1172/JCI4285

Hattori, 1998, Differential effects of anti-Fas ligand and anti-tumor necrosis factor-a antibodies on acute graft-versus-host disease pathologies, Blood, 91, 4051, 10.1182/blood.V91.11.4051

Vallera, 1995, Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice, Transplantation, 60, 1371

Clark, 2000, Neutralization of tumor necrosis factor-alpha action delays but does not prevent lung injury induced by alloreactive T helper 1 cells, Transplantation, 70, 39

Haddad, 1999, High levels of peroxynitrite are generated in the lungs of irradiated mice given cyclophosphamide and allogeneic T cells, Am J Respir Cell Mol Biol, 20, 1125, 10.1165/ajrcmb.20.6.3460

Hill, 2000, The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease, Blood, 95, 2754, 10.1182/blood.V95.9.2754.009k25_2754_2759

Cooke, 2001, LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation, J Clin Invest, 107, 1581, 10.1172/JCI12156

Fegan, 1990, The gut mucosal barrier in bone marrow transplantation, Bone Marrow Transplant, 5, 373

Cooke, 2002, The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease, J Endotoxin Res, 8, 441, 10.1179/096805102125001046

Maus, 2001, Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14, Am J Physiol Lung Cell Mol Physiol, 280, L58, 10.1152/ajplung.2001.280.1.L58

DiCarlo, 2003, Continuous veno-venous hemofiltration may improve survival from acute respiratory distress syndrome after bone marrow transplantation or chemotherapy, J Pediatr Hematol Oncol, 25, 801, 10.1097/00043426-200310000-00012

Yanik, 2004, Survival following etantercept therapy for the treatment of idiopathic pneumonia syndrome following allogeneic stem cell transplantation, Blood, 104, 104a, 10.1182/blood.V104.11.354.354

Cerveri, 2001, Lung function abnormalities after bone marrow transplantation in children, Chest, 120, 1900, 10.1378/chest.120.6.1900

Ringden, 1999, Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation, Blood, 93, 2196, 10.1182/blood.V93.7.2196

Ralph, 1984, Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease, Am Rev Respir Dis, 129, 641

Clark, 1989, Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course, Ann Intern Med, 111, 368, 10.7326/0003-4819-111-5-368

Sullivan, 1991, Chronic graft-versus-host disease and other late complications of bone marrow transplantation, Semin Hematol, 28, 250

d’Alessandro, 1996, Radiologic-pathologic conference of Children’s Hospital Boston, Pediatr Radiol, 26, 19, 10.1007/BF01403697

King, 1993, Overview of bronchiolitis, Clin Chest Med, 14, 607, 10.1016/S0272-5231(21)00924-2

Ooi, 1998, High-resolution computed tomography of bronchiolitis obliterans syndrome after bone marrow transplantation, Respiration, 65, 187, 10.1159/000029257

Bankier, 2001, Bronchiolitis obliterans syndrome in heart-lung transplant recipients, Radiology, 218, 533, 10.1148/radiology.218.2.r01fe09533

Dudek, 2003, Bronchiolitis obliterans in chronic graft-versus-host disease, Biol Blood Marrow Transplant, 9, 657, 10.1016/S1083-8791(03)00242-8

Beinert, 1996, Late pulmonary impairment following allogeneic bone marrow transplantation, Eur J Med Res, 1, 343

Holland, 1988, Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-versus-host disease and low serum IgG, Blood, 72, 621, 10.1182/blood.V72.2.621.621

Belperio, 2002, Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients, Transplantation, 73, 591, 10.1097/00007890-200202270-00020

Elssner, 2000, Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome, Transplantation, 70, 362, 10.1097/00007890-200007270-00022

Coker, 1998, Pulmonary fibrosis, Eur Respir J, 11, 1218, 10.1183/09031936.98.11061218

Sime, 1998, Transfer of tumor necrosis factor-a to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-b1 and myofibroblasts, Am J Pathol, 153, 825, 10.1016/S0002-9440(10)65624-6

Miyazaki, 1995, Expression of a tumor necrosis factor-a transgene in murine lung causes lymphocytic and fibrosing alveolitis, J Clin Invest, 96, 250, 10.1172/JCI118029

Payne, 1993, Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation, Chest, 104, 114, 10.1378/chest.104.1.114

Verleden, 2004, Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation, Transplantation, 77, 1465, 10.1097/01.TP.0000122412.80864.43

Gerhardt, 2003, Maintenance azithromycin therapy for bronchiolitis obliterans syndrome, Am J Respir Crit Care Med, 168, 121, 10.1164/rccm.200212-1424BC

Khalid, 2005, Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation, Eur Respir J, 25, 490, 10.1183/09031936.05.00020804

Chiang, 2002, Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease, Transplantation, 73, 665, 10.1097/00007890-200202270-00035

Yanik, 2003, Etanercept for sub-acute lung injury following allogeneic stem cell transplantation, Blood, 102, 471a

Thông tin
Thông tin xuất bản

Seminars in Hematology

Tập 43

42-52

Thông tin tác giả